United Therapeutics (UTHR) Misses Q3 EPS by 16c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $472.21 --0%
Revenue Growth %: -1.2%
Financial Fact:
Other, net: 1M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: -1.2%
Financial Fact:
Other, net: 1M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $7.16, $0.16 worse than the analyst estimate of $7.32. Revenue for the quarter came in at $799.5 million versus the consensus estimate of $812.87 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Strive Enterprises (ASST) Reiterated at Buy by StoneX on Launch of Digital Credit ETF
- Stock action shows confidence in central banks: BofA’s Hartnett
- Andersen Group (ANDG) PT Raised to $70 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
